CORRECTION article

Front. Oncol., 29 June 2021

Sec. Women's Cancer

Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.639813

Corrigendum: Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer

  • 1. Department of Anesthesiology, Dalian Medical University, Dalian, China

  • 2. Department of Anesthesiology, First Affiliated Hospital of Dalian Medical University, Dalian, China

  • 3. Department of Anesthesia and Intensive Care, School of Medicine and Health Science, University for Development Studies, Tamale, Ghana

  • 4. Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China

  • 5. Department of Biotechnology, Dalian Medical University, Dalian, China

  • 6. Department of Radiology, Dalian Medical University, Dalian, China

  • 7. Department of Clinical Microbiology, School of Medicine and Health Science, University for Development Studies, Tamale, Ghana

  • 8. School of Life Science and Bio-pharmaceutics, Shenyang Pharmaceutical University, Shenyang, China

  • 9. Department of Ophthalmology, First Affiliated Hospital of Dalian Medical University, Dalian, China

In the original article, there was a mistake in Figure 2 as published. We acknowledge making a mistake with the western blot used for Oct 4 in Figure 2D. The corrected Figure 2 appears below.

Figure 2

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Summary

Keywords

scorpion venom analgesic peptide, rBmK AGAP, stemness, epithelial-mesenchymal transition, pentraxin 3, Wnt/β-catenin signaling, transcription factor NF-κB, breast cancer

Citation

Kampo S, Ahmmed B, Zhou T, Owusu L, Anabah TW, Doudou NR, Kuugbee ED, Cui Y, Lu Z, Yan Q and Wen Q-P (2021) Corrigendum: Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer. Front. Oncol. 11:639813. doi: 10.3389/fonc.2021.639813

Received

09 December 2020

Accepted

13 May 2021

Published

29 June 2021

Volume

11 - 2021

Edited and reviewed by

Seema Singh, Mitchell Cancer Institute, United States

Updates

Copyright

*Correspondence: Qing-Ping Wen,

This article was submitted to Women’s Cancer, a section of the journal Frontiers in Oncology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics